HeartBeam (BEAT)
(Delayed Data from NSDQ)
$2.21 USD
+0.01 (0.45%)
Updated May 3, 2024 04:00 PM ET
After-Market: $2.23 +0.02 (0.90%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[BEAT]
Reports for Purchase
Showing records 61 - 80 ( 101 total )
Industry: Medical Services
Acquisition Rounds Out Cardiocore''s Core Lab Capabilities
Provider: The Benchmark Company
Analyst: WALD J
Industry: Medical Services
Research Update:Looking for operational efficiencies through its latest acquisition
Provider: STONEGATE CAPITAL MARKETS
Analyst: TRANG D
Industry: Medical Services
Solid 1Q. See Progress On Key Dimensions. Outlook Positive. Affirm Buy Rating And $18 PT
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B
Industry: Medical Services
WLP Update And Increasing Forecast To Reflect Recent Acquisition. Affirm Buy And $18 PT.
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B
Industry: Medical Services
Solid 4Q13 Results as Its Long-Term Strategy seems to Paying Off
Provider: The Benchmark Company
Analyst: WALD J
Industry: Medical Services
Industry: Medical Services
Industry: Medical Services
Looking for Growth in Healthcare Management and Finding it
Provider: The Benchmark Company
Analyst: WALD J
Industry: Medical Services
Update on MedNet Healthcare Technologies after a Conversation with Management
Provider: The Benchmark Company
Analyst: WALD J
Industry: Medical Services
Reiterate Buy, Patent Issues Resolved and Mednet Acquired
Provider: The Benchmark Company
Analyst: WALD J
Industry: Medical Services
Industry: Medical Services
Investment in Wellbridge Health CHF Monitoring a Positive
Provider: The Benchmark Company
Analyst: WALD J
Industry: Medical Services
Industry: Medical Services
Industry: Medical Services
Research Update:Medicare reimbursement changes presents hiccup for top line growth
Provider: STONEGATE CAPITAL MARKETS
Analyst: TRANG D
Industry: Medical Services
Medicare Cuts Likely To Reduce Revenue By 4%. Still Believe In Bright Future. Affirm Buy Rating And $15 PT.
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B
Industry: Medical Services
Sell-Off Overdone, Reimbursement Cut of 13.9% Likely Only a 3.6% Reduction in 2014 Revenues
Provider: The Benchmark Company
Analyst: WALD J
Industry: Medical Services
Research Update: BEAT: 5th straight quarter of revenue growth and new agreement signed
Provider: STONEGATE CAPITAL MARKETS
Analyst: TRANG D
Industry: Medical Services
Industry: Medical Services
A Good Quarter demonstrating New Strategy Appears to be Working
Provider: The Benchmark Company
Analyst: WALD J